Pill or insert? study tests best way to use misoprostol for early pregnancy loss
NCT ID NCT07526064
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares two ways of giving misoprostol—by mouth or vaginally—to women who have a missed abortion in the first trimester. The goal is to see which route works better and causes fewer side effects. One hundred women will take part, and researchers will measure how quickly the pregnancy tissue is expelled and whether any remains in the uterus.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- misoprostol
- What this could lead to
- If successful, this could help doctors choose the best route for misoprostol to manage missed abortion with fewer side effects.
- What could go wrong
- This is a small, early-phase trial (Phase 1) with only 100 participants. Results may not apply to all women, and the optimal route may still be unclear.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MISSED ABORTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
PNS Hafeez
Islamabad, 44000, Pakistan
More trials for these conditions
Other studies related to the condition(s) this trial covers.